NCT05603481View on ClinicalTrials.gov

CGM in Patients With ED's

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 9, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 2, 2024

Conditions
Anorexia Nervosa Restricting TypeAnorexia Nervosa, Binge Eating/Purging TypeARFIDAvoidant Restrictive Food Intake Disorder
Interventions
DEVICE

Continuous Glucose Monitor

Patients will wear a CGM device on their arm for 10 days, while receiving standard of care blood draws and finger stick sugar checks.

Trial Locations (1)

80204

Denver Health and Hospital Authority, Denver

All Listed Sponsors
lead

Denver Health and Hospital Authority

OTHER

NCT05603481 - CGM in Patients With ED's | Biotech Hunter | Biotech Hunter